The store will not work correctly when cookies are disabled.
methyl 3-(5-((3-oxobenzo[b]thiophen-2(3H)-ylidene)methyl)furan-2-yl)benzoate
ID: ALA4784600
PubChem CID: 1007404
Max Phase: Preclinical
Molecular Formula: C21H14O4S
Molecular Weight: 362.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1cccc(-c2ccc(/C=C3\Sc4ccccc4C3=O)o2)c1
Standard InChI: InChI=1S/C21H14O4S/c1-24-21(23)14-6-4-5-13(11-14)17-10-9-15(25-17)12-19-20(22)16-7-2-3-8-18(16)26-19/h2-12H,1H3/b19-12-
Standard InChI Key: XOXUDDMFGQEKSP-UNOMPAQXSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
10.3827 -8.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3815 -9.0286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0896 -9.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0878 -7.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7964 -8.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7967 -9.0286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5796 -9.2828 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.0634 -8.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5792 -7.9509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8315 -7.1736 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8806 -8.6163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2894 -9.3239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9540 -10.0680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5615 -10.6146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2691 -10.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0988 -9.4065 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.9735 -10.6126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9733 -11.4309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6807 -11.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3889 -11.4288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3851 -10.6073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6771 -10.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0920 -10.1946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8017 -10.5997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.0880 -9.3775 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8058 -11.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 2 0
8 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 17 1 0
23 24 1 0
23 25 2 0
21 23 1 0
24 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 362.41 | Molecular Weight (Monoisotopic): 362.0613 | AlogP: 5.06 | #Rotatable Bonds: 3 |
Polar Surface Area: 56.51 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.31 | CX LogD: 4.31 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.48 | Np Likeness Score: -1.11 |
References
1. Hou X,Sun JP,Ge L,Liang X,Li K,Zhang Y,Fang H. (2020) Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets., 190 [PMID:32078861] [10.1016/j.ejmech.2020.112131] |